The tumor suppressor LKB1 antagonizes WNT signaling pathway through modulating GSK3β activity in cell growth of esophageal carcinoma

Tumor Biology

Volumn 35, Issue 2, 2014, Pages 995-1002

  Liu, Kai ^a   Luo, Yue ^b   Tian, Hui ^a   Yu, Kai Zhong ^a   He, Jin Xian ^a   Shen, Wei Yu ^a  

^a Lihuili Hospital   (China)

^b WENZHOU MEDICAL UNIVERSITY   (China)

Author keywords

Esophageal carcinoma; GSK3 ; LKB1; WNT signaling pathway

Indexed keywords

BETA CATENIN; CYCLIN D1; GELATINASE A; GLYCOGEN SYNTHASE KINASE 3BETA; PROTEIN KINASE LKB1; SHORT HAIRPIN RNA; WNT PROTEIN;

ARTICLE; CANCER CELL CULTURE; CANCER GROWTH; CANCER STAGING; CANCER SURVIVAL; CELL PROLIFERATION; CONTROLLED STUDY; CYCLIN D1 GENE; DOWN REGULATION; ENZYME ACTIVITY; ENZYME PHOSPHORYLATION; ESOPHAGUS CARCINOMA; ESOPHAGUS MUCOSA; FEMALE; FZD2 GENE; GELATINASE A GENE; GENE OVEREXPRESSION; GENE SILENCING; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOPRECIPITATION; LENTIVIRINAE; LKB1 GENE; MAJOR CLINICAL STUDY; MALE; ONCOGENE C MYC; PATHOGENESIS; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; REAL TIME POLYMERASE CHAIN REACTION; TUMOR SUPPRESSOR GENE; UPREGULATION; WESTERN BLOTTING; WNT SIGNALING PATHWAY;

BETA CATENIN; CELL LINE, TUMOR; CELL PROLIFERATION; CYCLIN D1; ESOPHAGEAL NEOPLASMS; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; GENE KNOCKDOWN TECHNIQUES; GLYCOGEN SYNTHASE KINASE 3; HUMANS; MALE; PROTEIN-SERINE-THREONINE KINASES; WNT SIGNALING PATHWAY;

EID: 84899061298     PISSN: 10104283     EISSN: 14230380     Source Type: Journal    
DOI: 10.1007/s13277-013-1133-0     Document Type: Article

References (41)

1. Vallbohmer D, Brabender J, Metzger R, Holscher AH. Genetics in the pathogenesis of esophageal cancer: possible predictive and prognostic factors. J Gastrointest Surg. 2010;14 Suppl 1:S75-80.
2. Klein CA, Stoecklein NH. Lessons from an aggressive cancer: evolutionary dynamics in esophageal carcinoma. Cancer Res. 2009;69: 5285-8.
3. Knisely JP, Burtness BA, Salem RR. Surgical treatment of esophageal cancer. N Engl J Med. 2003;348:1177-9. author reply 1177-1179.
4. Kocher HM, Tekkis PP. Surgical treatment of esophageal cancer. N Engl J Med. 2003;348:1177-9. author reply 1177-1179.
5. Jiang W, Zhang YJ, Kahn SM, Hollstein MC, Santella RM, Lu SH, et al. Altered expression of the cyclin d1 and retinoblastoma genes in human esophageal cancer. Proc Natl Acad Sci U S A. 1993;90:9026-30. (Pubitemid 23306444)
6. Montesano R, Hollstein M, Hainaut P. Genetic alterations in esophageal cancer and their relevance to etiology and pathogenesis: a review. Int J Cancer. 1996;69:225-35. (Pubitemid 26233303)
7. Kuwano H, Kato H, Miyazaki T, Fukuchi M, Masuda N, Nakajima M, et al. Genetic alterations in esophageal cancer. Surg Today. 2005;35:7-18. (Pubitemid 40941123)
8. Igaki H, Sasaki H, Kishi T, Sakamoto H, Tachimori Y, Kato H, et al. Highly frequent homozygous deletion of the p16 gene in esophageal cancer cell lines. BiochemBiophys Res Commun. 1994;203:1090-5. (Pubitemid 24304941)
9. Ylikorkala A, Rossi DJ, Korsisaari N, Luukko K, Alitalo K, Henkemeyer M, et al. Vascular abnormalities and deregulation of VEGF in LKB1-deficient mice. Science. 2001;293:1323-6. (Pubitemid 32777423)
10. Watts JL, Morton DG, Bestman J, Kemphues KJ. The C. elegans par-4 gene encodes a putative serine-threonine kinase required for establishing embryonic asymmetry. Development. 2000;127:1467-75. (Pubitemid 30232597)
11. Hemminki A, Markie D, Tomlinson I, Avizienyte E, Roth S, Loukola A, et al. A serine/threonine kinase gene defective in Peutz-Jeghers syndrome. Nature. 1998;391:184-7. (Pubitemid 28092478)
12. van Lier MG, Wagner A, Mathus-Vliegen EM, Kuipers EJ, Steyerberg EW, van Leerdam ME. High cancer risk in Peutz-Jeghers syndrome: a systematic review and surveillance recommendations. Am J Gastroenterol. 2010;105:1258-64. author reply 1265.
13. Avizienyte E, Loukola A, Roth S, Hemminki A, Tarkkanen M, Salovaara R, et al. LKB1 somatic mutations in sporadic tumors. Am J Pathol. 1999;154:677-81. (Pubitemid 29122586)
14. Avizienyte E, Roth S, Loukola A, Hemminki A, Lothe RA, Stenwig AE, et al. Somatic mutations in LKB1 are rare in sporadic colorectal and testicular tumors. Cancer Res. 1998;58:2087-90. (Pubitemid 28232890)
15. Sato N, Rosty C, Jansen M, Fukushima N, Ueki T, Yeo CJ, et al. STK11/LKB1 Peutz-Jeghers gene inactivation in intraductal papillary-mucinous neoplasms of the pancreas. Am J Pathol. 2001;159:2017-22. (Pubitemid 33104257)
16. Wang ZJ, Churchman M, Campbell IG, Xu WH, Yan ZY, McCluggage WG, et al. Allele loss and mutation screen at the Peutz-Jeghers (LKB1) locus (19p13.3) in sporadic ovarian tumours. Br J Cancer. 1999;80:70-2. (Pubitemid 29210090)
17. Sanchez-Cespedes M. A role for LKB1 gene in human cancer beyond the Peutz-Jeghers syndrome. Oncogene. 2007;26:7825-32. (Pubitemid 350261789)
18. Guldberg P, thor Straten P, AhrenkielV, Seremet T, Kirkin AF, Zeuthen J. Somatic mutation of the Peutz-Jeghers syndrome gene, LKB1/STK11, in malignant melanoma. Oncogene. 1999;18:1777-80.
19. Tiainen M, Vaahtomeri K, Ylikorkala A, Makela TP. Growth arrest by the LKB1 tumor suppressor: induction of p21(waf1/cip1). Hum Mol Genet. 2002;11:1497-504. (Pubitemid 34679250)
20. Tiainen M, Ylikorkala A, Makela TP. Growth suppression by LKB1 is mediated by a g(1) cell cycle arrest. Proc Natl Acad Sci U S A. 1999;96:9248-51. (Pubitemid 29374740)
21. Kim DW, Chung HK, Park KC, Hwang JH, Jo YS, Chung J, et al. Tumor suppressor LKB1 inhibits activation of signal transducer and activator of transcription 3 (STAT3) by thyroid oncogenic tyrosine kinase rearranged in transformation (RET)/papillary thyroid carcinoma (PTC). Mol Endocrinol. 2007;21:3039-49. (Pubitemid 350223513)
22. Chen Y, Wu X, Bu S, He C, Wang W, Liu J, et al. Promising outcomes of definitive chemoradiation and cetuximab for patients with esophageal squamous cell carcinoma. Cancer Sci. 2012;103: 1979-84.
23. Clements WM, Wang J, Sarnaik A, Kim OJ, MacDonald J, Fenoglio-Preiser C, et al. Beta-catenin mutation is a frequent cause of WNT pathway activation in gastric cancer. Cancer Res. 2002;62:3503-6. (Pubitemid 34651399)
24. Barker N, Clevers H. Catenins, WNT signaling and cancer. Bioessays. 2000;22:961-5.
25. Polakis P. WNT signaling and cancer. Genes Dev. 2000;14:1837-51. (Pubitemid 30639518)
26. Holland JD, Klaus A, Garratt AN, Birchmeier W. WNT signaling in stem and cancer stem cells. Curr Opin Cell Biol. 2013;25: 254-64.
27. Mizushima T, Nakagawa H, Kamberov YG, Wilder EL, Klein PS, Rustgi AK. WNT-1 but not epidermal growth factor induces beta-catenin/t-cell factor-dependent transcription in esophageal cancer cells. Cancer Res. 2002;62:277-82. (Pubitemid 34074015)
28. Nakanishi Y, Ochiai A, Akimoto S, Kato H, Watanabe H, Tachimori Y, et al. Expression of e-cadherin, alpha-catenin, beta-catenin and plakoglobin in esophageal carcinomas and its prognostic significance: immunohistochemical analysis of 96 lesions. Oncology. 1997;54:158-65. (Pubitemid 27101765)
29. Kadowaki T, Shiozaki H, Inoue M, Tamura S, Oka H, Doki Y, et al. E-cadherin and alpha-catenin expression in human esophageal cancer. Cancer Res. 1994;54:291-6.
30. Ossipova O, Bardeesy N, DePinho RA, Green JB. LKB1 (XEEK1) regulates WNT signalling in vertebrate development. Nat Cell Biol. 2003;5:889-94. (Pubitemid 37220694)
31. Lin-Marq N, Borel C, Antonarakis SE. Peutz-Jeghers lkb1 mutants fail to activate gsk-3beta, preventing it from inhibitingWnt signaling. Mol Genet Genomics. 2005;273:184-96. (Pubitemid 40674718)
32. Spicer J, Rayter S, Young N, Elliott R, Ashworth A, Smith D. Regulation of the WNT signalling component par1a by the Peutz-Jeghers syndrome kinase LKB1. Oncogene. 2003;22: 4752-6. (Pubitemid 36976450)
33. Chen J, Kesari S, Rooney C, Strack PR, Chen J, Shen H, et al. Inhibition of notch signaling blocks growth of glioblastoma cell lines and tumor neurospheres. Genes Cancer. 2010;1:822-35.
34. Mehenni H, Lin-Marq N, Buchet-Poyau K, Reymond A, Collart MA, Picard D, et al. Lkb1 interacts with and phosphorylates PTEN: a functional link between two proteins involved in cancer predisposing syndromes. Hum Mol Genet. 2005;14:2209-19. (Pubitemid 41418020)
35. Schmidt AI, Reismann M, Kubler JF, Vieten G, Bangen C, Shimotakahara A, et al. Exposure to carbon dioxide and helium reduces in vitro proliferation of pediatric tumor cells. Pediatr Surg Int. 2006;22:72-7. (Pubitemid 43052203)
36. Espada J, Calvo MB, Diaz-Prado S, Medina V. WNT signalling and cancer stem cells. Clin Transl Oncol. 2009;11:411-27.
37. Reya T, Clevers H. WNT signalling in stem cells and cancer. Nature. 2005;434:843-50. (Pubitemid 40558990)
38. Evan GI, Vousden KH. Proliferation, cell cycle and apoptosis in cancer. Nature. 2001;411:342-8. (Pubitemid 32467043)
39. Lu XJ, Luo JD, Ling Y, Kong YZ, Feng LL, Zhou J, et al. Management of small cell carcinoma of esophagus in China. J Gastrointest Surg. 2013;17(7):1181-7.
40. Takubo K, Makuuchi H, Arima M, Aida J, Arai T. Vieth M: [lymph node metastasis in superficial squamous carcinoma of the esophagus]. Pathologe. 2013;34:148-54.
41. Shackelford DB, Shaw RJ. The LKB1-AMPK pathway: metabolism and growth control in tumour suppression. Nat Rev Cancer. 2009;9: 563-75.